How Emergency Departments Handle Cannabis-Related Emergencies ↗
Clinical review outlining how emergency departments should diagnose and manage cannabis-related emergencies, distinguishing between natural and synthetic cannabinoid presentations.
Browse more cannabis research, findings, methods, and limitations.
Clinical review outlining how emergency departments should diagnose and manage cannabis-related emergencies, distinguishing between natural and synthetic cannabinoid presentations.
Proof-of-concept study testing a technology-delivered health communication intervention to reduce cannabis misuse among 64 college students.
Cannabis vapor activated cancer, inflammation, and oxidative stress genes in human lung cells—without triggering DNA damage, suggesting a unique harm mechanism.
Large national survey of 187,573 people showing significantly higher cannabis marketing exposure in recreational-legal states compared to medical-only or prohibition states.
Three-arm RCT finding that placebo effects account for significant improvements attributed to low-dose CBD oil for psychological distress in university students.
Lab study showing CBD can protect human cartilage cells from ferroptosis (iron-dependent cell death), suggesting a potential mechanism for joint protection relevant to osteoarthritis.
Case report of two children with treatment-resistant Tourette syndrome who used cannabis-based medicine for 5-6 years, providing rare long-term pediatric follow-up data.
Preclinical study showing cannabis extract reduces inflammation in a rat dermatitis model, supporting potential applications for inflammatory skin conditions.
Clinical trial in 60 adults showing that legal hemp CBD products containing trace THC can trigger positive drug tests, with effects depending on THC dose level.
Prospective cohort study finding that new medical cannabis patients with anxiety and depression showed improvements over 6 months using real-time symptom monitoring.
Survey of German midwives after 2024 cannabis legalization finding gaps in knowledge about prenatal cannabis risks and inconsistent screening practices.
Review of current pharmacological and non-pharmacological treatments for cannabinoid hyperemesis syndrome in the emergency department setting.
Driving simulator study of 88 adults showing edible cannabis impairs driving performance, with effects varying by usage frequency and driving environment.
Analysis of drug use in non-fatal motor vehicle crashes in 2023, examining how state cannabis legalization policies relate to drug-positive crash rates.
Longitudinal study of 387 adolescents finding that social and environmental predictors of substance initiation differ for alcohol vs. cannabis, moderated by family addiction history.
Preclinical study showing that mice lacking the endocannabinoid enzyme NAPE-PLD have altered stress responses that depend on the type of stress context.
Preclinical study showing mice without the endocannabinoid enzyme NAPE-PLD have sex-dependent changes in opioid and natural reward responsiveness.
Canadian cannabis retailers in Newfoundland cited high taxes, advertising restrictions, and supply chain issues as barriers—while recognizing their public health role.
Among 71 older cannabis users, 86% had genetic variants altering cannabinoid metabolism—explaining why the same dose affects people so differently.
Systematic review and meta-analysis showing CBD consistently reduces neuroinflammation in preclinical Alzheimer's models with promising but limited clinical signals.
EMA study of 88 co-users finding that simultaneous alcohol and cannabis use paradoxically increases both perceived impairment and willingness to drive.
Comprehensive review of cannabis use in pregnancy and breastfeeding, covering pharmacology, evidence on outcomes, and harm reduction counseling strategies.
Deep learning analysis of 2.9 million cannabis tweets showing predominantly positive/neutral attitudes, with medical value and difficulty quitting as dominant positive and negative themes.
Experimental marketplace study of 1,250 cannabis users showing potency-based taxes are more effective than price-based taxes at reducing demand for high-THC products.
Analysis of 175,493 Americans showing recreational cannabis legalization is associated with falling asleep 7 minutes later and sleeping 5 minutes less per night.
Choice experiment with 1,100 youth showing cannabis taxes reduce consumption but potency-based taxes paradoxically increase low-THC product use and may drive illegal market substitution.
Researchers mapped an amygdala-hippocampus brain circuit where endocannabinoids are naturally released during anxiety to dampen fear responses, using novel viral tools.
Clinical review clarifying how cyclic vomiting syndrome and cannabinoid hyperemesis syndrome overlap in symptoms but differ in causes and treatment approaches.
Preclinical study showing CBD inhibits osteosarcoma growth by directly binding NF-kB and disrupting an inflammatory signaling loop, validated in cell and mouse models.
Analysis of 15 years of national data showing cannabis-using smokers are significantly more responsive to cigarette price increases than non-cannabis-using smokers.
Cannabis therapy achieved 91.5% response in 200 neuropathic pain patients over 4 years—and a novel biomarker tracked anxiety 6x better than pain.
Preclinical study showing cannabinoids drive appetite by activating AgRP hunger neurons in the brain, with neuron ablation eliminating the munchies effect.
Six-month study in Alzheimer's mice showing CB1 receptor activation reduces tau pathology and neuroinflammation while blocking CB1 worsens all disease measures.
Analysis of 264,380 Ohio child welfare cases showing substance involvement spiked from 32% to 42% in early 2020, driven by increases in cannabis and polysubstance use.
Preclinical study showing THC and CBD both suppress B-cell immune activation but through distinct metabolic pathways that differ between young and aged mice.
Cannabis-like compounds magnolol and amorfrutin 2 from non-cannabis plants show antiseizure effects in Dravet and Lennox-Gastaut mouse models through T-type calcium channel inhibition.
PET imaging study of 29 people showing 13% lower dopamine D2 receptor availability in those testing positive for tobacco and/or cannabis smoke metabolites.
Lab study showing CBD kills extensively drug-resistant A. baumannii and synergizes with antibiotics, reducing needed antibiotic concentrations by up to 1,000-fold through membrane disruption.
Mystery shopper study finding only 40% of California budtenders advise against prenatal cannabis use, while 80% warn against tobacco — highlighting a critical public health gap.
Large study of 40,806 pregnancies showing daily preconception cannabis use increases the risk of prenatal use 2.7-fold, highlighting the need for early intervention.
Study of 200,207 pregnancies showing prenatal cannabis users initiate breastfeeding at similar rates but discontinue earlier, with 16-19% lower rates at 6-12 months.
Analysis of 356,343 pregnancies finding daily cannabis use associated with 3.8x greater odds of severe morning sickness, challenging the use of cannabis for pregnancy nausea.
Study of 297,147 infants finding prenatal alcohol (but not cannabis or nicotine) exposure associated with 37% increased risk of infant hearing loss.
Study of 3,507 pregnant cannabis users finding smoking is most common (71%), with significant sociodemographic differences in how cannabis is consumed during pregnancy.
Large study of 141,570 children finding no association between maternal prenatal cannabis use and ADHD or disruptive behavior disorders after adjusting for confounders.
ABCD Study analysis of 11,854 children finding prenatal cannabis exposure associated with 58% higher odds of hallucinatory-like psychotic experiences, distinct from genetically-driven paranoid symptoms.
Comprehensive mouse study confirming cannabigerol (CBG) is non-intoxicating at any blood concentration or route of administration, supporting its safety for wellness products.
Preclinical study showing THC disrupts prefrontal cortex myelination in female rats during early adolescence, with intensive exposure causing permanent changes and increased risk-taking.
Survey of 153 Canadian nursing students revealing 86-90% report knowledge gaps in cannabis regulations, effectiveness, and dosing practices.
Large national study finding GAD significantly associated with cannabis use disorder under DSM-5 criteria, with different patterns for lifetime vs. past-year diagnoses.